Abbott Laboratories stock page - price, fundamentals, dividends - iOCharts

ABT

123.31
+3.97 (3.33%)
Abbott Laboratories (NYSE, USD)
Healthcare >
Medical Devices
Market cap
219.10B
Ent value
250.04B
Price/Sales
6.33
Price/Book
6.48
Div yield
1.46%
Div growth
8.45%
Growth years
8
FCF payout
54.21%
Trailing P/E
48.74
Forward P/E
26.58
PEG
4.23
EPS growth
12.40%
1 year return
13.80%
3 year return
21.86%
5 year return
24.53%
10 year return
17.19%
Last updated: 2021-10-20

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open123.53
Daily high124.79
Daily low122.20
Daily Volume7.65M
All-time high129.06
1y analyst estimate125.81
Beta0.68
EPS (TTM)2.54
Dividend per share1.80
Ex-div date14 Jul 2021
Next earnings date20 Oct 2021

Downside potential

Loading...
Downside potential data
ABTS&P500
Current price drop from All-time high-4.46%-0.17%
Highest price drop-46.27%-56.47%
Date of highest drop23 Jul 20029 Mar 2009
Avg drop from high-11.23%-11.45%
Avg time to new high19 days12 days
Max time to new high1275 days1805 days

DIVIDENDS

Dividend yield - 5y

Loading...
Dividend yield data
Dividend per share1.80
Dividend yield1.46%
Payout frequencyQuarterly
Maximum yield2.82%
Average yield1.80%
Minimum yield1.29%
Discount to avg yield-23.48%
Upside potential-19.02%
Yield as % of max yield51.78%

Yield distribution (inverse percentile) - 5y

Loading...
Yield distribution data
Dividend yield1.46%
Current yield distribution90.95%
Yield at 100% (Min)1.29%
Yield at 90%1.47%
Yield at 80%1.53%
Yield at 50% (Median)1.70%
Yield at 20%2.04%
Yield at 10%2.37%
Yield at 0% (Max)2.82%

Dividend per share

Loading...
Dividend per share data
Years of growth8 years
CCC statusDividend Challenger
Dividend per share1.80
Payout frequencyQuarterly
Ex-div date14 Jul 2021
EPS (TTM)2.54
EPS (1y forward)4.64
EPS growth (5y)12.40%
EPS growth (5y forward)11.53%

Dividend growth

Loading...
Please create a free account or log in to access this chart
Dividend growth data
ABTS&P500
DGR MR25.00%7.68%
DGR TTM22.14%-2.66%
DGR 3 years10.75%5.82%
DGR 5 years8.45%6.23%
DGR 10 years5.76%9.64%
DGR 15 years7.04%6.71%
Time since last change announced317 days
EPS growth (5y)12.40%
EPS growth (5y forward)11.53%

Payout ratio

Loading...
Please create a free account or log in to access this chart
Payout ratio data
EPS coverageFCF coverage
TTM56.95%54.21%
Average--
Forward38.79%-

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E48.74
Price to OCF27.73
Price to FCF46.40
Price to EBITDA26.41
EV to EBITDA30.14

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales6.33
Price to Book6.48
EV to Sales7.22

FINANCIALS

Per share

Loading...
Per share data
Current share count1.78B
EPS (TTM)2.54
FCF per share (TTM)2.67

Income statement

Loading...
Income statement data
Revenue (TTM)34.61B
Gross profit (TTM)19.61B
Operating income (TTM)5.36B
Net income (TTM)4.50B
EPS (TTM)2.54
EPS (1y forward)4.64

Margins

Loading...
Margins data
Gross margin (TTM)56.65%
Operating margin (TTM)15.48%
Profit margin (TTM)12.99%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash8.05B
Net receivables8.06B
Total current assets21.82B
Goodwill23.38B
Intangible assets14.18B
Property, plant and equipment8.83B
Total assets72.78B
Accounts payable11.51B
Short/Current long term debt18.44B
Total current liabilities12.46B
Total liabilities39.00B
Shareholder's equity33.79B
Net tangible assets5.04B

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)7.90B
Capital expenditures (TTM)3.18B
Free cash flow (TTM)4.72B
Dividends paid (TTM)2.56B

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity13.62%
Return on Assets6.20%
Return on Invested Capital8.69%
Cash Return on Invested Capital9.12%
COMPANY DETAILS
ABT (Abbott Laboratories) company logo
Marketcap
219.10B
Marketcap category
Large-cap
Description
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded in 1888 and is based in North Chicago, Illinois.
Employees
109000
SEC filings
CEO
Robert Ford
Country
USA
City
Abbott Park
Stock type
Common stock
CCC status
Dividend Challenger
Dividend Frequency
Quarterly
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
In this article, we will take a look at the 10 stocks making moves on financial results. You can skip our detailed analysis of these companies, and go directly to the 5 Stocks Making Moves on Financia...
October 21, 2021
Abbott Laboratories (NYSE: ABT) has given investors plenty to like through the years. Abbott provided its third-quarter update before the market opened on Wednesday. Here are three things that inves...
October 21, 2021
Abbott Laboratories (ABT), a multinational medical devices and health care company, reported better-than-expected third-quarter results driven by solid COVID-19 related sales, new product approvals, a...
October 21, 2021
The S&P 500 and the Dow climbed on Wednesday with the Dow hitting an intraday record high as investors eyed better than expected third-quarter earnings from U.S. companies. While the Nasdaq lagged as...
October 20, 2021
Abbott Laboratories (NYSE: ABT) easily surmounted Hump Day, rising by 3.4% and trouncing the S&P 500 index's gain as it did so. For the quarter, Abbott posted year-over-year sales growth of 23%, as i...
October 20, 2021
Abbott Laboratories squashed third-quarter estimates Wednesday, helped by $1.9 billion in sales of Covid tests. ABT stock rose in response.
October 20, 2021
The S&P 500 and the Dow closed higher on Wednesday as investors eyed better than expected third-quarter earnings from U.S. companies. While the Nasdaq lagged as technology stocks took a breather, the...
October 20, 2021
The Dow briefly touched a record high and the S&P 500 traded close to its peak on Wednesday as investors eyed better than expected third-quarter earnings from U.S. companies. While the Nasdaq lagged ...
October 20, 2021
With the exception of any participants' questions asked during the question-and-answer session, the entire call, including the question-and-answer session, is material copyrighted by Abbott. It canno...
October 20, 2021
The S&P 500 and the Dow inched closer to record highs on Wednesday after strong forecasts from healthcare companies Anthem and Abbott, while the Nasdaq lagged as technology stocks took a breather. Th...
October 20, 2021
Next page